Relay Therapeutics (RLAY) Net Margin (2020 - 2025)
Historic Net Margin for Relay Therapeutics (RLAY) over the last 6 years, with Q2 2025 value amounting to 10301.62%.
- Relay Therapeutics' Net Margin changed N/A to 10301.62% in Q2 2025 from the same period last year, while for Sep 2025 it was 3551.78%, marking a year-over-year decrease of 1017200.0%. This contributed to the annual value of 3374.86% for FY2024, which is 20362700.0% down from last year.
- Latest data reveals that Relay Therapeutics reported Net Margin of 10301.62% as of Q2 2025.
- Over the past 5 years, Relay Therapeutics' Net Margin peaked at 8349600.0% during Q4 2023, and registered a low of 82765.55% during Q2 2023.
- Its 5-year average for Net Margin is 538492.43%, with a median of 11897.0% in 2021.
- Per our database at Business Quant, Relay Therapeutics' Net Margin plummeted by 2000000000bps in 2021 and then surged by 2000000000bps in 2023.
- Relay Therapeutics' Net Margin (Quarter) stood at 11897.0% in 2021, then tumbled by -124bps to 26671.54% in 2022, then soared by 31405bps to 8349600.0% in 2023, then crashed by -100bps to 813.55% in 2024, then tumbled by -1166bps to 10301.62% in 2025.
- Its Net Margin stands at 10301.62% for Q2 2025, versus 1003.46% for Q1 2025 and 813.55% for Q1 2024.